To assess the functional consequences of these variants, Kavanagh et al.25assessed the FI antigenic levels in serum in a single AMD cohort and demonstrated that rare variants in CFI causing low levels (type I variants) are the predominant driver of AMD risk (OR 13.6). The gene discussed is CFI; the disease is age-related macular degeneration.